Skip to main content
Xenon Pharmaceuticals Inc. logo

Xenon Pharmaceuticals Inc. — Investor Relations & Filings

Ticker · XENE ISIN · CA98420N1050 LEI · 549300XV44Q9Z1MIPQ03 US Manufacturing
Open in API
Filings indexed 746 across all filing types
Latest filing 2016-05-27 Director's Dealing
Country CA Canada
Listing US XENE

About Xenon Pharmaceuticals Inc.

https://www.xenon-pharma.com/

Xenon Pharmaceuticals Inc. is a neuroscience-focused biopharmaceutical company dedicated to the discovery, clinical development, and commercialization of therapeutics for neurological and psychiatric disorders. The company leverages its expertise in human genetics and a deep understanding of ion channel biology to develop medicines that modulate ion channels, targeting the central and peripheral nervous systems. Its late-stage pipeline includes azetukalner, an investigational candidate being developed for the treatment of epilepsy and depression.

Recent filings

Filing Released Lang Actions
Director's Dealing 2016
Director's Dealing
2016-05-27 English
10-Q
Interim / Quarterly Report Q1 2016
2016-05-10 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 10, 2016, reporting the company's financial results for the quarter ended March 31, 2016. It specifically states that the financial results were announced via a press release attached as Exhibit 99.1. The text indicates that the 8-K and the press release are furnished but not filed, and the document itself is a current report announcing the earnings results. The document length is 2837 characters, which is relatively short and primarily serves as an announcement of the earnings release rather than containing detailed financial statements or analysis. According to the classification rules, initial announcements of quarterly financial results (key highlights only) correspond to the Earnings Release (ER) category. Therefore, this document should be classified as an Earnings Release (ER).
2016-05-10 English
OWNERSHIP DOCUMENT
Director's Dealing
2016-04-30 English
DEF 14A
Proxy Solicitation & Information Statement
2016-04-27 English
Regulatory Filings 2016
Regulatory Filings
2016-04-27 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.